The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A global database of COVID-19 vaccinations
Open accessPublished version of a preprint
Abstract
An effective rollout of vaccinations against COVID-19 offers the most promising prospect of bringing the pandemic to an end. We present the Our World in Data COVID-19 vaccination dataset, a global public dataset that tracks the scale and rate of the vaccine rollout across the world. This dataset is updated regularly and includes data on the total number of vaccinations administered, first and second doses administered, daily vaccination rates and population-adjusted coverage for all countries for which data are available (169 countries as of 7 April 2021). It will be maintained as the global vaccination campaign continues to progress. This resource aids policymakers and researchers in understanding the rate of current and potential vaccine rollout; the interactions with non-vaccination policy responses; the potential impact of vaccinations on pandemic outcomes such as transmission, morbidity and mortality; and global inequalities in vaccine access. The Our World in Data COVID-19 vaccination tracker charts the scale and rate of global vaccinations against COVID-19, making the data available to scientists, policymakers and the general public
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Yet, this pandemic has become a race between effective vaccines and the new variants.”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accessibility to effective COVID-19 vaccines, particularly mRNA vaccines, remains very limited in many LMICs 17 , and the main goal of ChulaCov19 development is to be part of the solution to this problem.”
From Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trial (2022) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“By the end of 2021, Australia, Cambodia, China, Hong Kong SAR, New Zealand, Singapore, and Viet Nam had all achieved full vaccination rates of adult populations of more than 60%.”
From The Lancet Commission on lessons for the future from the COVID-19 pandemic (2022) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)
Hale, T., Angrist, N., Goldszmidt, R., Kira, B., Petherick, A., Phillips, T., Webster, S., Cameron-Blake, E., Hallas, L., Majumdar, S., et al. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01079-8 · Cited by 4,578
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Dagan, N., Barda, N., Kepten, E., Miron, O., Perchik, S., Katz, M. A., Hernán, M. A., Lipsitch, M., Reis, B., & Balicer, R. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101765 · Cited by 2,527 · cited 1×
“Integrating it with 93 other epidemiological data can help researchers evaluate these outcomes.(16,17) Evidence of 94 positive impacts of vaccination on transmission and mortality can also in turn help to 95 strengthen public trust.”
BackgroundSherman, S. M., Smith, L. E., Sim, J., Amlôt, R., Cutts, M., Dasch, H., Rubin, G. J., & Sevdalis, N. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1846397 · Cited by 758
Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination
Kreps, S., Prasad, S., Brownstein, J. S., Hswen, Y., Garibaldi, B. T., Zhang, B., & Kriner, D. L. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.25594 · Cited by 732
A cross-country database of COVID-19 testing
Hasell, J., Mathieu, E., Beltekian, D., Macdonald, B., Giattino, C., Ortiz-Ospina, E., Roser, M., & Ritchie, H. (2020) · Scientific Data · doi:10.1038/s41597-020-00688-8 · Cited by 662
Self-citationLooking beyond COVID-19 vaccine phase 3 trials
Kim, J. H., Marks, F., & Clemens, J. D. (2021) · Nature Medicine · doi:10.1038/s41591-021-01230-y · Cited by 585
Israel’s rapid rollout of vaccinations for COVID-19
Rosen, B., Waitzberg, R., & Israeli, A. (2021) · Israel Journal of Health Policy Research · doi:10.1186/s13584-021-00440-6 · Cited by 271
Restoring confidence in vaccines in the COVID-19 era
Verger, P., & Dubé, E. (2020) · Expert Review of Vaccines · doi:10.1080/14760584.2020.1825945 · Cited by 221
An interactive website tracking COVID-19 vaccine development
Shrotri, M., Swinnen, T., Kampmann, B., & Parker, E. P. K. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00043-7 · Cited by 144 · cited 1×
“Other research groups have combined it with vaccine development data to provide a 86 complete overview of the global vaccine landscape.(14) It has been used by researchers 87 looking at the role of vaccine hesitancy, and how to design public messaging based on these 88 concerns.”
Background
Cited by
Tregoning, J. S., Flight, K. E., Higham, S. L., Wang, Z., & Pierce, B. F. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00592-1 · Cited by 1,125
The Lancet Commission on lessons for the future from the COVID-19 pandemic
Sachs, J. D., Karim, S. S. A., Aknin, L., Allen, J., Brosbøl, K., Colombo, F., Barron, G. C., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01585-9 · Cited by 842
Dong, E., Ratcliff, J., Goyea, T. D., Katz, A., Lau, R., Ng, T. K., Garcia, B., Bolt, E., Prata, S., Zhang, D., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00434-0 · Cited by 283
“18 For example, doses administered beyond a full series (eg, three doses of the mRNA-1273 [Moderna] vaccine) have been described as both additional and booster doses.”
BackgroundClinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., Rampotas, A., Ambler, G., & Makris, M. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2109908 · Cited by 587
New‐onset autoimmune phenomena post‐COVID‐19 vaccination
Chen, Y., Xu, Z., Wang, P., Li, X., Shuai, Z., Ye, D., & Pan, H. (2022) · Immunology · doi:10.1111/imm.13443 · Cited by 502
“As of 6 September 2021, 40·4% of the population worldwide have been given at least one dose of a COVID19 vaccine, and 5·45 billion doses have been administered globally [11].”
Background
Metadata
- Authors
- Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., Giattino, C., & Rodés-Guirao, L.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Ritchie, Hannah
- ORCID
- Venue
- Nature Human Behaviour
- Published
- 2021-05-10
- Volume
- 5
- Issue
- 7
- Pages
- 947-953
- ISSN
- 2397-3374 (ISSN-L)
- OpenAlex
- W3160918102
- Cited by
- 1,974
- References
- 19
- Citations by year
- 2026: 72 · 2025: 134 · 2024: 306 · 2023: 598 · 2022: 668 · 2021: 194
- FWCI
- 244.05
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-06-17)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Human Behaviour (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation (INV-008629)
- Department of Health and Social Care
- University of Oxford
- Topics
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 vaccination, vaccine rollout, vaccination coverage, global health disparities, vaccine access, pandemic outcomes, Our World in Data
- MeSH terms
- Vaccination Coverage, COVID-19, COVID-19 Vaccines, Humans, Immunization Schedule, Vaccination, Global Health, Immunization Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A global database of COVID-19 vaccinations. https://app.cochat.ai/papers/10.1038/s41562-021-01122-8
- The paper
- Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., Giattino, C., & Rodés-Guirao, L. (2021). A global database of COVID-19 vaccinations. Nature Human Behaviour. https://doi.org/10.1038/s41562-021-01122-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.